Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

June 30, 2007

Conditions

Ankylosing Spondylitis

Interventions

DRUG

Enbrel (etanercept)

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00434044 - Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter